Psychiatric implications of anticonvulsant drugs.
The spectrum of contemporary antiepileptics are categorically reviewed with reference to adverse behavioral sequelae. These iatrogenic disturbances may have peripheral (eg. heptatic dysfunction, blood dyscrasia, or lupus-like syndromes) or central (eg. altered neurotransmission) manifestations. Whether an idiosyncratic reaction, toxic circumstance, or untoward drug interaction, there is scant understanding of the predisposing factors or recognition of the neuropsychiatric influence of anticonvulsant therapy.
D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects*; D001569:Benzodiazepines; D002220:Carbamazepine / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced*; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011324:Primidone / Q000009:adverse effects; D014635:Valproic Acid / Q000009:adverse effects
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D001569:Benzodiazepines; D011324:Primidone; D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin; D010634:Phenobarbital